UPLOAD Filing
TEVA PHARMACEUTICAL INDUSTRIES LTD
Date: April 28, 2025 · CIK: 0000818686 · Accession: 0000000000-25-004469
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-16174
Letter
Re: Teva Pharmaceutical Industries Limited Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-16174 Dear Amir Weiss:
April 28, 2025
Amir Weiss SVP Finance, Chief Accounting Officer Teva Pharmaceutical Industries Limited 124 Dvora HaNevi'a Street Tel Aviv, Israel 6944020
We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 28, 2025 Amir Weiss SVP Finance, Chief Accounting Officer Teva Pharmaceutical Industries Limited 124 Dvora HaNevi'a Street Tel Aviv, Israel 6944020 Re: Teva Pharmaceutical Industries Limited Form 10-K for the Fiscal Year Ended December 31, 2024 File No. 001-16174 Dear Amir Weiss: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>